Cargando…

1107. Three Year Longitudinal Assessment of Pseudomonas aeruginosa (Pa) Antibiotic Susceptibility in Children with Cystic Fibrosis (CF) in the Era of Modulator Therapy

BACKGROUND: CF is a genetic disease characterized by chronic lung infection, often with Pseudomonas aeruginosa (Pa). It is widely accepted that increasing antibiotic resistance develops in Pa following repeated antibiotic exposure. With the advent of elexacaftor/tezacaftor/ivacaftor (ETI) modulator...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bradley, John, Stout, Dayna, Akong, Kathryn, Fireizen, Yaron
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677408/ http://dx.doi.org/10.1093/ofid/ofad500.080

Ejemplares similares

2578. Trends in Pathogens and Antibiotic Treatment in Children with Cystic Fibrosis in 2018 and 2022: A Retrospective Multicenter Study
por: Stout, Dayna, et al.
Publicado: (2023)

The Susceptibility of Pseudomonas aeruginosa Strains from Cystic Fibrosis Patients to Bacteriophages
por: Essoh, Christiane, et al.
Publicado: (2013)

Clinical and microbiological characteristics of cystic fibrosis adults never colonized by Pseudomonas aeruginosa: Analysis of the French CF registry
por: Vongthilath, Réchana, et al.
Publicado: (2019)

Evaluation of tests to predict metallo-β-lactamase in cystic fibrosis (CF) and non-(CF) Pseudomonas
por: Perez, Leandro Reus Rodrigues, et al.
Publicado: (2014)

The Microbiology of Non-aeruginosa Pseudomonas Isolated From Adults With Cystic Fibrosis: Criteria to Help Determine the Clinical Significance of Non-aeruginosa Pseudomonas in CF Lung Pathology
por: Moore, John E., et al.
Publicado: (2022)

152* Microevolution of the major common Pseudomonas aeruginosa clones C and PA14 in cystic fibrosis lungs
por: Cramer, N., et al.
Publicado: (2011)

Pseudomonas aeruginosa PA80 is a cystic fibrosis isolate deficient in RhlRI quorum sensing
por: Ahmed, Syed A. K. Shifat, et al.
Publicado: (2021)

TACKLING ANTIMICROBIAL RESISTANCE (AMR) - IN VITRO EFFECT OF SODIUM CHLORIDE ON ANTIBIOTIC SUSCEPTIBILITY IN CLINICAL PSEUDOMONAS AERUGINOSA ISOLATED FROM PATIENTS WITH CYSTIC FIBROSIS (CF)
por: Gramegna, Andrea, et al.
Publicado: (2020)

13. Evaluation of Etest for Antibiotic Susceptibility and Minimum Inhibitory Concentration (MIC) Agreement Against pseudomonas Aeruginosa (psa) from Patients with Cystic Fibrosis (CF)
por: Lasko, Maxwell J, et al.
Publicado: (2020)

INCREASING BURDEN OF ANTIMICROBIAL RESISTANCE IN PSEUDOMONAS AERUGINOSA FROM ADULT PATIENTS WITH CYSTIC FIBROSIS (CF) IN NORTHERN IRELAND: THEN AND NOW
por: Gramegna, Andrea, et al.
Publicado: (2018)

Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial
por: Hewer, Simon C Langton, et al.
Publicado: (2020)

Development and validation of the Cystic Fibrosis Decisional Balance for Physical Activity scale (CF-DB-PA)
por: Filleul, Valentine, et al.
Publicado: (2021)

Eradication of Pseudomonas aeruginosa in adults with cystic fibrosis
por: Kenny, S L, et al.
Publicado: (2014)

Microevolution of Pseudomonas aeruginosa in cystic fibrosis lungs
por: Cramer, Nina, et al.
Publicado: (2014)

Heterogeneous Antimicrobial Susceptibility Characteristics in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
por: Qin, Xuan, et al.
Publicado: (2018)

Polymicrobial Interactions in the Cystic Fibrosis Airway Microbiome Impact the Antimicrobial Susceptibility of Pseudomonas aeruginosa
por: Reece, Emma, et al.
Publicado: (2021)

Draft Genome Sequence of the Multidrug-Resistant Strain Pseudomonas aeruginosa PA291, Isolated from Cystic Fibrosis Sputum
por: Luong, Tiffany, et al.
Publicado: (2021)

Early detection of Pseudomonas aeruginosa – comparison of conventional versus molecular (PCR) detection directly from adult patients with cystic fibrosis (CF)
por: Xu, Jiru, et al.
Publicado: (2004)

Fermentation products in the cystic fibrosis airways induce aggregation and dormancy-associated expression profiles in a CF clinical isolate of Pseudomonas aeruginosa
por: Phan, Joann, et al.
Publicado: (2018)

Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis
por: Sordé, Roger, et al.
Publicado: (2011)

Cystic fibrosis lung environment and Pseudomonas aeruginosa infection
por: Bhagirath, Anjali Y., et al.
Publicado: (2016)

Interactions between Neutrophils and Pseudomonas aeruginosa in Cystic Fibrosis
por: Rada, Balázs
Publicado: (2017)

Coinfection with Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis
por: Keown, Karen, et al.
Publicado: (2020)

Heterogenous Susceptibility to R-Pyocins in Populations of Pseudomonas aeruginosa Sourced from Cystic Fibrosis Lungs
por: Mei, Madeline, et al.
Publicado: (2021)

2395. Mechanism-Based-Susceptibility Testing (MBST) Using Disc Diffusion Assays (DDA) to Guide Treatment of Multidrug- and Extensively Drug-Resistant Pseudomonas aeruginosa (MDR-XDR-Pa) in a Cystic Fibrosis (CF) Lung Transplant Recipient; Are We Ready for Combination Therapy vs. MDR-XDR-Pa?
por: Abbo, Lilian M, et al.
Publicado: (2018)

1602. Comparative Activity of Ceftolozane-Tazobactam (C/T) and Ceftazidime-Avibactam (CZA) against Pseudomonas aeruginosa (PSA) from Patients with Cystic Fibrosis (CF)
por: Lasko, Maxwell J, et al.
Publicado: (2020)

Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
por: Høiby, Niels
Publicado: (2011)

Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
por: Hurley, Matthew N., et al.
Publicado: (2012)

The Effect of Strict Segregation on Pseudomonas aeruginosa in Cystic Fibrosis Patients
por: van Mansfeld, Rosa, et al.
Publicado: (2016)

Adherence of Pseudomonas aeruginosa to cystic fibrosis buccal epithelial cells
por: Lingner, Meike, et al.
Publicado: (2017)

Interaction between Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis
por: Zhao, Jingming, et al.
Publicado: (2018)

ePS5.01 Cystic fibrosis (CF) patients chronically infected with Pseudomonas aeruginosa have widespread alterations in both innate and adaptive immunity
por: Lausen, M., et al.
Publicado: (2022)

Improving the care of patients with cystic fibrosis (CF)
por: Khan, Ahsan Aftab, et al.
Publicado: (2017)

Does Pseudomonas aeruginosa Colonization Affect Exercise Capacity in CF?
por: Kampouras, Asterios, et al.
Publicado: (2019)

Inhalation with Fucose and Galactose for Treatment of Pseudomonas Aeruginosa in Cystic Fibrosis Patients
por: Hauber, Hans-Peter, et al.
Publicado: (2008)

Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection.
por: Pukhalsky, A L, et al.
Publicado: (1999)

Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice
por: Wang, Yufa, et al.
Publicado: (2010)

Phenotypic Heterogeneity of Pseudomonas aeruginosa Populations in a Cystic Fibrosis Patient
por: Workentine, Matthew L., et al.
Publicado: (2013)

Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis
por: Knibbs, Luke D, et al.
Publicado: (2014)

Molecular Epidemiology of Chronic Pseudomonas aeruginosa Airway Infections in Cystic Fibrosis
por: Cramer, Nina, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_p2h768255hss2suoqbe74oe31m